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Dual Infection by 
Dengue Virus and 
Shigella sonnei in 
Patient Returning 
from India
To the Editor: Two days after
returning from a 4-week trip in India,
a 44-year-old woman was admitted to
a local French hospital with diarrhea
and a fever (40°C). The fever had
started 2 days before her return and
was associated with myalgia and
backache. The patient had not been
vaccinated against yellow fever and
did not take malaria prophylaxis dur-
ing her trip. Blood smears were nega-
tive for malaria parasites. Biological
analyses (complete blood count, liver
enzymes, urine culture, stool culture,
blood cultures) were ordered. She was
sent home with an empirical treatment
with ofloxacin (200 mg per day). Bio-
logical parameters were within the
normal range, except for her platelet
count, which was at the lower limit
(170 G/L). Microbiologic analyses of
stools yielded an isolate of Shigella
sonnei serotype 9. 
One week later, the patient was
admitted to the infectious diseases unit
of a university hospital in Marseilles,
France, with persistent fever, myal-
gia, and a 7-kg weight loss; she had no
digestive manifestations. Results of
viral serology tests were negative,
except that immunoglobulin (Ig)M,
but not IgG, specific for dengue virus
(formal name: Dengue virus;
[DENV]) was present. This result was
obtained with the Dengue Virus IgM
and IgG Rapid Immunochromato-
graphic Card Test (Biotrin, PanBio
Pty. Ltd., Brisbane, Australia) and was
confirmed by the Dengue Duo IgM-
capture and IgG-capture enzyme-
linked immunosorbent assay (ELISA)
(PanBio) and a previously described
in-house IgM antibody capture ELISA
tests (1). Forty days later, a second
serum specimen was collected and
tested positive for DENV IgG with the
persistence of IgM by three tech-
niques. In light of these results, the
diagnosis of primary dengue infection
was established, according to criteria
of the Centers for Disease Control and
Prevention (2). A literature review did
not find any documented case of coin-
fection by DENV and Shigella. 
In India, DENV causes epidemic
and sporadic cases year-round, with a
peak in frequency from August to
November, during the humid season
(3). During the patient’s trip, she suc-
cessively visited Mumbai (Bombay);
went north to the Shimla district, Him-
achal Pradesh, the Agra district, and
Uttar Pradesh; and came back to Bom-
bay 3 days before leaving for France.
If one assumes a 3- to 6-day incuba-
tion period, she likely acquired the
dengue infection in Uttar Pradesh; the
virus has been reported to circulate in
this area (4).
Although severe forms are
increasingly reported, most cases of
dengue fever consist of a mild illness
with nonspecific symptoms such as
headache, myalgia, and malaise. Den-
gue fever may go underdiagnosed in
travelers returning from DENV-
endemic areas. This case underlines
the importance of a thorough inter-
view and clinical examination to
detect characteristic signs (photopho-
bia, painful ocular mobilization, skin
rash) in patients returning from areas
endemic for dengue fever, when clini-
cal and biological signs incompletely
correlate with the primary diagnosis.
Since dengue fever is the second most
frequent cause of febrile illness in per-
sons returning from tropical areas,
such patients should be routinely
screened for the disease.
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St. Louis 
Encephalitis 
in Argentina: The 
First Case Reported 
in the Last 
Seventeen Years
To the Editor: St. Louis encepha-
litis is a mosquito-borne viral disease
that affects humans. The causative
agent, SLEV (formal name: Saint
Louis encephalitis virus), is a member
of the Flaviviridae family. Severity of
the clinical syndromes increases with
age, and persons >60 years old have
the highest frequency of encephalitis.
The primary transmission cycle
involves wild passeriform and colum-
biform birds, and Culex sp. mosqui-
toes (1). In Argentina, an urban cycle
may involve Cx. quinquefasciatus,
which is a source of a viral isolate, and
abundant birds (house sparrows,
doves, or chickens) (2). The distribu-
tion of SLEV in Argentina is wide;
seroprevalence ranges from 3% to
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50% of the country’s population (3).
Spinsanti et al. reported results of a
serologic screening in persons ages 0–
87 years who live in the city of Cór-
doba; antibodies were most frequently
found in persons >60 years of age (4).
However, cases of St. Louis encephali-
tis reported in Argentina are very rare.
Two cases with serologic diagnosis
were reported in 1964 and 1968,
respectively (2). In 1971, two more
cases were diagnosed on the basis of
viral isolation (5). Finally, the last case
reported was a patient with menin-
goencephalitis diagnosed in the prov-
ince of Buenos Aires by hemaggluti-
nation inhibition assay (6). Herein, we
report a case of Saint Louis encephali-
tis that occurred in the province of
Córdoba, Argentina.
A 61-year-old man was admitted
to the hospital in February 2002, com-
plaining of headache, fever, and diplo-
pia. He had been well until 3 months
before admission, when ophthalmic
herpes zoster was diagnosed. He
underwent therapy with oral acyclovir
and had a good clinical outcome. Ten
days before admission, he developed
unstable gait with misbalance and
hand tremors, mainly at his left side.
On admission, he had occipital head-
ache, diplopia, and nausea and vomit-
ing associated with high fever and
chills. Somnolence appeared a few
hours before the consultation.
The patient was a right-handed
businessman, a native of Córdoba. He
was married and had no risk factors
for sexually transmitted diseases. He
had not traveled inside or outside the
country during the last year. He lived
near a river with a high-density popu-
lation of mosquitoes.
Vital signs on admission showed
axillary temperature of 39°C, pulse of
90 beats per minute, respiratory fre-
quency of 20 per minute, and blood
pressure of 110/70 mmHg. Physical
examination demonstrated a somno-
lent patient who was easily aroused
and oriented. His speech was slurred.
Results of a fundoscopic examination
appeared normal. Results of a cranial-
nerve examination showed horizontal
left diplopia with left sixth nerve pare-
sia. A resting, postural, and intentional
hand tremor was evident. Motor
strength was 5/5 throughout with nor-
mal bulk and tone, tendon reflexes,
and coordination. Examination of sen-
sitivity showed no abnormalities. A
slight neck rigidity was detected.
Routine laboratory analysis was
unremarkable, and results of serologic
tests for coxsackie virus, echovirus,
and HIV were negative. HIV-1 RNA
by polymerase chain reaction (PCR)
and p24 antigen were also negative.
Cerebrospinal fluid study revealed a
leukocyte count of 18/mm3 (80% lym-
phocytes), a glucose level of 48 mg/
dL, and a protein level of 87 mg/dL.
Cryptococcal antigen, antibodies for
syphilis, Human herpesvirus 1 and 2,
and PCR for varicella-zoster virus 1
and Human herpesvirus were also
negative. Results of an electroenceph-
alogram and a chest radiograph were
normal. Therapy with intravenous
acyclovir was initiated. A magnetic
resonance imaging (MRI) scan of the
brain showed a striking signal change
on T2 in the substantia nigra of the
midbrain, mainly at the right side.
The patient continued febrile,
diplopia disappeared, and meningeal
signs progressed with frank cervical
stiffness, positive Kerning sign, and
photophobia. Diffuse tremulousness
and axial rigidity appeared. Upper
extremities showed rigidity with cog-
wheel phenomenon. Conversely,
lower extremities showed spasticity
with bilateral Babinski sign. Tendon
reflexes became enhanced. His gait
showed retropulsion with wide base
sustentation. Dysdiadochokinesia ap-
peared. On the third day, a new lumbar
puncture showed worse results: a leu-
kocyte count of 210/mm3 (82% lym-
phocytes), a glucose level of 51 mg/
dL, and a protein level of 106 mg/dL.
Another electroencephalographic
examination showed unspecific cen-
troparietal disorganization with right
side predominance. Intravenous acy-
clovir was stopped. On the 5th day, the
patient began to recover; he was dis-
charged on the 10th day. After 3
months of follow-up, only left arm
rigidity and a left hand tremor per-
sisted.
Acute- and convalescent-phase
serum samples (taken 10 and 16 days
after onset of illness, respectively)
were sent to the Arbovirus and
Arenavirus Disease Laboratory, Insti-
tuto de Virología, Córdoba. SLEV
immunoglobulin (Ig) M antibodies
were positive by indirect immunofluo-
rescence assay (IFA). Seroconversion
for IgG antibodies was demonstrated
by IFA (7) and hemagglutination inhi-
bition assay, with titers of 640 and 80
in the first sample and 2,560 and 320
in the second sample. These results
were confirmed by neutralization test
using the reduction of plates technique
in Vero cells culture, as described (8).
Eastern equine encephalomyelitis
virus and Western equine encephalo-
myelitis viruses with known circula-
tion in Argentina were included in the
assay with negative results (3). An
increase in antibodies titers between
acute- (320) and convalescent-phase
(1,280) samples was found only for
SLEV. Among other flaviviruses, den-
gue, yellow fever, and Ilhéus circulate
only in subtropical areas of Argentina
(the province of Córdoba is not
included in this area); only dengue
virus was investigated (by neutraliza-
tion test) because of a current epide-
miologic surveillance program; results
were negative. No evidence that West
Nile virus is currently circulating or
has entered Argentina was found, so
we did not perform tests to detect it
(2,9). Isolation of SLEV from the
cerebrospinal fluid and blood was
attempted in newborn mice and Vero
cell cultures with negative results.
While the typical clinical manifes-
tations of viral encephalitis (fever,
headache, and altered level of con-
sciousness) are indistinguishable from
each other, tremor and other extrapy-
ramidal signs are described in St.
Louis encephalitis and Japanese
encephalitis (10). The typical MRI
finding of patients with St. Louis
encephalitis is localized in the sub-
stantia nigra (11). 
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In summary, the occurrence of St.
Louis encephalitis in a 61-year-old
patient, after >10 years of no reports
in Argentina, along with specific epi-
demiology, suggest that further studies
are needed to assess the risk for
human infection by SLEV in Argen-
tina and the role of several mosquito
species in its transmission.
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Streptomyces 
bikiniensis 
Bacteremia
To the Editor: Carey et al.
recently reported in this journal a case
of catheter-related bacteremia attrib-
uted to Streptomyces in a patient
receiving holistic infusions (1). We
describe the isolation of Streptomyces
bikiniensis from multiple blood cul-
tures in a single patient over the
course of 1 week, further illustrating
that Streptomyces is pathogenic and a
cause of bacteremia even in the
absence of overt clinical symptoms
and risk factors.
A 14-year-old girl with osteosar-
coma of the right proximal tibia came
to our hospital 13 months after diag-
nosis for her final course of chemo-
therapy. At the time of diagnosis, a
double-lumen central venous catheter
was inserted. Her course was compli-
cated by poor response to chemother-
apy, and a limb salvage procedure was
performed 3 months after diagnosis.
The proximal tibia was replaced with
a cadaveric bone graft. Several hours
after the patient received methotrex-
ate, a fever of 39.2°C developed. No
sign of infection was observed on
physical examination. Her leukocyte
count was 6,300 cells/mm3 with an
absolute neutrophil count of 4,914
cells/mm3. She received a single dose
of acetaminophen and was without
fever for the remainder of her hospi-
talization. A blood culture obtained
from the central venous catheter at the
time of fever grew Streptomyces.
Repeat blood cultures obtained from
both ports of the central venous cathe-
ter on day 3 and a peripheral blood
culture obtained on day 4 also grew
Streptomyces. Treatment with vanco-
mycin and cotrimoxazole was started
on day 4 in the hospital. The Strepto-
myces isolate was susceptible to van-
comycin, amikacin, cotrimoxazole,
erythromycin, cephazolin, and tetracy-
cline and was resistant to ampicillin,
penicillin, oxacillin, and clindamycin.
A blood culture drawn from the cen-
tral venous catheter on day 3 of antibi-
otic therapy (the 6th day in the
hospital) grew Streptomyces after 9
days of incubation. All subsequent
blood cultures were without growth.
The central venous catheter was
removed, and the patient received van-
comycin intravenously for 6 weeks,
without recurrence of Streptomyces
bacteremia.
The bone graft was considered a
potential source of infection. As most
cases of disease from Streptomyces
occur in the tropics, we requested
information on whether the donor
traveled or resided outside the United
States. However, the donor had no his-
tory of travel outside the United
States. All cultures taken from the
donor and the graft were without
growth (although this did not exclude
the graft as the source of infection),
